These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28631072)

  • 21. Trimethylamine N-Oxide increases soluble fms-like tyrosine Kinase-1 in human placenta via NADPH oxidase dependent ROS accumulation.
    Chang QX; Chen X; Ming-Xin Yang ; Zang NL; Li LQ; Zhong N; Xia LX; Huang QT; Zhong M
    Placenta; 2021 Jan; 103():134-140. PubMed ID: 33120049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression and significance of soluble fms-like tyrosine kinase 1 in preeclampsia placenta].
    Ye YH; Liu L; Zhan Y; Peng W
    Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):521-4. PubMed ID: 17083834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activating Transcription Factor 3 Is Reduced in Preeclamptic Placentas and Negatively Regulates sFlt-1 (Soluble fms-Like Tyrosine Kinase 1), Soluble Endoglin, and Proinflammatory Cytokines in Placenta.
    Kaitu'u-Lino TJ; Brownfoot FC; Hastie R; Chand A; Cannon P; Deo M; Tuohey L; Whitehead C; Hannan NJ; Tong S
    Hypertension; 2017 Nov; 70(5):1014-1024. PubMed ID: 28947613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity.
    Palmer KR; Kaitu'u-Lino TJ; Hastie R; Hannan NJ; Ye L; Binder N; Cannon P; Tuohey L; Johns TG; Shub A; Tong S
    Hypertension; 2015 Dec; 66(6):1251-9. PubMed ID: 26416849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Pravastatin on Human Placenta, Endothelium, and Women With Severe Preeclampsia.
    Brownfoot FC; Tong S; Hannan NJ; Binder NK; Walker SP; Cannon P; Hastie R; Onda K; Kaitu'u-Lino TJ
    Hypertension; 2015 Sep; 66(3):687-97; discussion 445. PubMed ID: 26222708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Placental expression of soluble fms-like tyrosine kinase 1 is increased in singletons and twin pregnancies with intrauterine growth restriction.
    Nevo O; Many A; Xu J; Kingdom J; Piccoli E; Zamudio S; Post M; Bocking A; Todros T; Caniggia I
    J Clin Endocrinol Metab; 2008 Jan; 93(1):285-92. PubMed ID: 17956955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble FMS-Like Tyrosine Kinase-1: Role in placenta accreta spectrum disorder.
    Lumbanraja S; Yaznil MR; Siahaan AM; Berry Eka Parda B
    F1000Res; 2021; 10():618. PubMed ID: 36127888
    [No Abstract]   [Full Text] [Related]  

  • 28. Advanced glycation end products as an upstream molecule triggers ROS-induced sFlt-1 production in extravillous trophoblasts: a novel bridge between oxidative stress and preeclampsia.
    Huang QT; Zhang M; Zhong M; Yu YH; Liang WZ; Hang LL; Gao YF; Huang LP; Wang ZJ
    Placenta; 2013 Dec; 34(12):1177-82. PubMed ID: 24144948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Placental-specific sFLT-1: role in pre-eclamptic pathophysiology and its translational possibilities for clinical prediction and diagnosis.
    Palmer KR; Tong S; Kaitu'u-Lino TJ
    Mol Hum Reprod; 2017 Feb; 23(2):69-78. PubMed ID: 27986932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin II induces soluble fms-Like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy.
    Zhou CC; Ahmad S; Mi T; Xia L; Abbasi S; Hewett PW; Sun C; Ahmed A; Kellems RE; Xia Y
    Circ Res; 2007 Jan; 100(1):88-95. PubMed ID: 17158338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of hypoxia and exogenous IL-10 on the pro-inflammatory cytokine TNF-alpha and the anti-angiogenic molecule soluble Flt-1 in placental villous explants.
    Royle C; Lim S; Xu B; Tooher J; Ogle R; Hennessy A
    Cytokine; 2009 Jul; 47(1):56-60. PubMed ID: 19501525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Edaravone inhibits hypoxia-induced trophoblast-soluble Fms-like tyrosine kinase 1 expression: a possible therapeutic approach to preeclampsia.
    Zhao Y; Zheng YF; Luo QQ; Yan T; Liu XX; Han L; Zou L
    Placenta; 2014 Jul; 35(7):476-82. PubMed ID: 24840734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular mechanisms of preeclampsia.
    Mutter WP; Karumanchi SA
    Microvasc Res; 2008 Jan; 75(1):1-8. PubMed ID: 17553534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
    Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
    Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Occult placenta accreta: the missing link in the diagnosis of abnormal placentation.
    Stanek J; Drummond Z
    Pediatr Dev Pathol; 2007; 10(4):266-73. PubMed ID: 17638431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta.
    Brownfoot FC; Tong S; Hannan NJ; Hastie R; Cannon P; Kaitu'u-Lino TJ
    BMC Pregnancy Childbirth; 2016 May; 16():117. PubMed ID: 27207105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Elevated SFLT-1 on the Regulation of Placental Transporters in Women With Pre-Eclampsia.
    Kojovic D; V Workewych N; Piquette-Miller M
    Clin Transl Sci; 2020 May; 13(3):580-588. PubMed ID: 31917511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR133b is involved in endogenous hydrogen sulfide suppression of sFlt-1 production in human placenta.
    Hu TX; Guo X; Wang G; Gao L; He P; Xia Y; Gu H; Ni X
    Placenta; 2017 Apr; 52():33-40. PubMed ID: 28454695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extravillous trophoblast invasion in placenta accreta is associated with differential local expression of angiogenic and growth factors: a cross-sectional study.
    Duzyj CM; Buhimschi IA; Laky CA; Cozzini G; Zhao G; Wehrum M; Buhimschi CS
    BJOG; 2018 Oct; 125(11):1441-1448. PubMed ID: 29469945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging.
    Jauniaux E; Collins S; Burton GJ
    Am J Obstet Gynecol; 2018 Jan; 218(1):75-87. PubMed ID: 28599899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.